Table 3.
Serum Ca (mg/dL) | Urinary Ca (mg in 24 h) | |||||
---|---|---|---|---|---|---|
Parameters | Predosing | Week 2 | Week 4 | Predosing | Week 2 | Week 4 |
Sham | 10.95 ± 0.19 | 11.14 ± 0.25 | 10.89 ± 0.16 | 0.74 ± 0.09 | 0.79 ± 0.09 | 0.60 ± 0.06 |
NX-1% vehicle | 10.91 ± 0.20 | 11.90 ± 0.32 | 11.07 ± 0.34 | 1.86 ± 0.28 | 1.48 ± 0.33 | 1.54 ± 0.27 |
NX-5% vehicle | 11.18 ± 0.23 | 10.46 ± 0.14 | 9.86 ± 0.40 | 1.70 ± 0.23 | 1.91 ± 0.34 | 1.63 ± 0.29 |
0.2% sevelamer | 11.37 ± 0.22 | 11.82 ± 0.41 | 11.98 ± 0.27 | 1.40 ± 0.15 | 2.22 ± 0.63 | 2.12 ± 0.65 |
1% sevelamer | 11.00 ± 0.16 | 10.91 ± 0.18 | 11.28 ± 0.14 | 1.72 ± 0.28 | 2.10 ± 0.28 | 2.33 ± 0.24 |
5% sevelamer | 11.39 ± 0.27 | 11.05 ± 0.29 | 10.52 ± 0.29 | 1.97 ± 0.23 | 3.38 ± 0.73a | 3.32 ± 0.74a |
0.2% VS-501 | 11.14 ± 0.16 | 11.48 ± 0.12 | 11.82 ± 0.22 | 0.95 ± 0.08 | 0.90 ± 0.06 | 1.14 ± 0.10 |
1% VS-501 | 11.06 ± 0.16 | 11.02 ± 0.36 | 11.30 ± 0.13 | 1.48 ± 0.14 | 1.12 ± 0.10 | 1.23 ± 0.11 |
5% VS-501 | 10.82 ± 0.18 | 11.25 ± 0.20 | 11.06 ± 0.18 | 1.90 ± 0.22 | 2.01 ± 0.33 | 2.02 ± 0.33 |
Data are mean ± SE. A t-test was used to assess differences between predosing and post dosing in the same group.
P < 0.05 versus predosing, same group. Predosing: Week 6 after surgery. Week 2: Week 8 after surgery with 2 weeks of dosing. Week 4: Week 10 after surgery with 4 weeks of dosing. Vehicle: unprocessed plant polymer. Sham rats were on high-Pi diet with no addition of vehicle or binders.